SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis

Saisai Guo1, Xiaobo Lei2, Yan Chang3

  • 1Department of Immunology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Insights

Researchers identified Cyclin-dependent kinase 2 (CDK2) as a crucial host factor for SARS-CoV-2 RNA replication. CDK2 inhibition effectively reduces viral RNA synthesis and infection, highlighting it as a promising target for new antiviral drugs.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • The COVID-19 pandemic underscores the urgent need for broad-spectrum antiviral therapies.
  • Identifying host factors essential for SARS-CoV-2 replication is key to developing effective treatments and pandemic preparedness.

Purpose of the Study:

  • To identify host proteins interacting with SARS-CoV-2 nonstructural protein 12 (nsp12), the RNA-dependent RNA polymerase (RdRp).
  • To investigate the role of identified host factors in viral RNA synthesis and SARS-CoV-2 infection.
  • To evaluate potential therapeutic targets for antiviral drug development.

Main Methods:

  • Mass spectrometry (MS)-based proteomics was employed to identify host proteins associated with SARS-CoV-2 nsp12.
  • The interaction between CDK2 and nsp12 was confirmed, and nsp12 phosphorylation at T20 by CDK2 was analyzed.
  • The effect of CDK2 inhibitors on viral RNA synthesis and SARS-CoV-2 infection was assessed.

Main Results:

  • Host protein Cyclin-dependent kinase 2 (CDK2) was identified as a nsp12-interacting protein.
  • CDK2 facilitates the assembly of the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) complex (nsp12, nsp7, nsp8) by phosphorylating nsp12 at T20.
  • CDK2 promotes efficient viral RNA synthesis and SARS-CoV-2 infection.
  • CDK2 inhibitors significantly impair viral RNA synthesis and reduce SARS-CoV-2 infection.

Conclusions:

  • CDK2 is a critical host factor for SARS-CoV-2 RNA replication and RdRp complex formation.
  • CDK2 represents a promising therapeutic target for the development of novel SARS-CoV-2 antiviral drugs.

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
80
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
132